Top Stories
-
New combination chemotherapies have improved survival for patients with pancreatic cancer, and oncologist Gulam Manji sees early signs that new treatments in trials may be even better.
-
Columbia researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
Topic
-
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
Topic
-
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
Topic
Latest News
- February 27, 2017
Bristol-Myers Squibb Company today announced that Columbia University Medical Center and Peter MacCallum Cancer Centre have joined the International Immuno-Oncology Network.
Topic
- February 14, 2017
In her JAMA editorial, Columbia oncologist Dawn Hershman says clinical trials show cooling caps reduce hair loss in some women undergoing chemotherapy.
Topic
- January 12, 2017
Collaboration will investigate a system biology approach to identifying treatment options for patients with advanced gastrointestinal stromal tumors (GIST).
Topic
- December 22, 2016
Columbia University researchers have created a user-friendly program that rapidly predicts which genes are implicated in an individual’s cancer and recommends treatments.
Topic
- December 16, 2016
Researchers have found that blocking nerve growth factor inhibits the formation of stomach cancers, according to a study in mice.
Topic
- December 5, 2016
In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
Topic
- November 21, 2016
Three CUMC scientists have been named AAAS Fellows: Max Gottesman, Wei Gu, and Paul Sajda.
Topic
- November 4, 2016
Dr. Drake studies the body’s immunological response to radiation therapy and how immunotherapy and radiation therapy can be used in concert to treat cancer.
Topic
- September 14, 2016
In mice studies, targeting the SET protein revives p53, a potent tumor suppressor, and prevents cancer growth.
Topic
- July 21, 2016
Adding a new drug called olaratumab to traditional chemotherapy increased survival in sarcoma patients, researchers at Columbia University Medical Center have found.
Topic
